tiprankstipranks
Argenx (ARGX)
NASDAQ:ARGX
US Market
ARGX
Argenx Se
RESEARCH TOOLSreports
Want to see ARGX full AI Analyst Report?

Argenx Se (ARGX) Stock Forecast & Price Target

871 Followers
See the Price Targets and Ratings of:

ARGX Analyst Ratings

Strong Buy
22Ratings
Strong Buy
20 Buy
2 Hold
0 Sell
Based on 22 analysts giving stock ratings to
Argenx
Se
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ARGX Stock 12 Month Forecast

Average Price Target

$1,143.90
▲(24.58% Upside)
Based on 22 Wall Street analysts offering 12 month price targets for Argenx Se in the last 3 months. The average price target is $1,143.90 with a high forecast of $1,353.00 and a low forecast of $932.00. The average price target represents a 24.58% change from the last price of $918.22.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"672":"$672","1013":"$1,013","1354":"$1,354","842.5":"$842.5","1183.5":"$1,183.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1353,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$1.35K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1143.9,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$1.14K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":932,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$932.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[672,842.5,1013,1183.5,1354],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,853.82,892.2184615384616,930.6169230769231,969.0153846153846,1007.4138461538462,1045.8123076923077,1084.2107692307693,1122.6092307692306,1161.0076923076922,1199.4061538461538,1237.8046153846153,1276.2030769230769,1314.6015384615384,{"y":1353,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,853.82,876.1338461538462,898.4476923076924,920.7615384615385,943.0753846153847,965.3892307692308,987.703076923077,1010.0169230769231,1032.3307692307694,1054.6446153846155,1076.9584615384615,1099.2723076923078,1121.586153846154,{"y":1143.9,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,853.82,859.8338461538463,865.8476923076923,871.8615384615385,877.8753846153846,883.8892307692308,889.9030769230769,895.9169230769231,901.9307692307692,907.9446153846154,913.9584615384615,919.9723076923077,925.9861538461539,{"y":932,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":673.8,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":706.41,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":767.33,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 52,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":818.5,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 36,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":894.9,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":840.95,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":835.68,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 49,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":756.76,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":743.12,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":783.5,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":836.09,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 56,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":909.5,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 76,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":853.82,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 65,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$1,353Average Price Target$1,144Lowest Price Target$932.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on ARGX
Douglas Tsao
H.C. Wainwright
H.C. Wainwright
$1,202
Buy
30.91%
Upside
Reiterated
08/18/26
Argenx price target raised to $1,202 from $940 at H.C. WainwrightArgenx price target raised to $1,202 from $940 at H.C. Wainwright
Wedbush Analyst forecast on ARGX
David Nierengarten
Wedbush
Wedbush
$1,050→$1,150
Buy
25.24%
Upside
Reiterated
08/18/26
Argenx price target raised to $1,150 from $1,050 at WedbushArgenx price target raised to $1,150 from $1,050 at Wedbush
Morgan Stanley Analyst forecast on ARGX
Sean Laaman
Morgan Stanley
Morgan Stanley
$1,200→$1,230
Buy
33.95%
Upside
Reiterated
08/18/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Argenx Se (NASDAQ: ARGX), Fulcrum Therapeutics (NASDAQ: FULC) and OmniAb (NASDAQ: OABI)
Citizens JMP Analyst forecast on ARGX
Jason Butler
Citizens JMP
Citizens JMP
$932→$1,200
Buy
30.69%
Upside
Reiterated
08/18/26
Argenx price target raised to $1,200 from $932 at CitizensArgenx price target raised to $1,200 from $932 at Citizens
Truist Financial Analyst forecast on ARGX
Danielle Brill
Truist Financial
Truist Financial
$1,030→$1,095
Buy
19.25%
Upside
Assigned
08/18/26
Argenx price target raised to $1,095 from $1,030 at TruistArgenx price target raised to $1,095 from $1,030 at Truist
Oppenheimer Analyst forecast on ARGX
Leland Gershell
Oppenheimer
Oppenheimer
$1,037→$1,100
Buy
19.80%
Upside
Reiterated
08/18/26
Argenx price target raised to $1,100 from $1,037 at OppenheimerArgenx price target raised to $1,100 from $1,037 at Oppenheimer
Citi Analyst forecast on ARGX
Samantha Semenkow
Citi
Citi
$1,203→$1,301
Buy
41.69%
Upside
Reiterated
08/18/26
Argenx Se (ARGX) Receives a Buy from Citi
TD Cowen Analyst forecast on ARGX
Yaron Werber
TD Cowen
TD Cowen
$1,146→$1,353
Buy
47.35%
Upside
Reiterated
08/17/26
Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX) and Amgen (NASDAQ: AMGN)
Piper Sandler Analyst forecast on ARGX
Allison Bratzel
Piper Sandler
Piper Sandler
$1,075→$1,215
Buy
32.32%
Upside
Reiterated
08/17/26
Argenx price target raised to $1,215 from $1,075 at Piper SandlerArgenx price target raised to $1,215 from $1,075 at Piper Sandler
Bank of America Securities Analyst forecast on ARGX
Tazeen Ahmad
Bank of America Securities
Bank of America Securities
$1,088→$1,136
Buy
23.72%
Upside
Reiterated
08/17/26
Argenx price target raised to $1,136 from $1,088 at BofAArgenx price target raised to $1,136 from $1,088 at BofA
William Blair Analyst forecast on ARGX
Matt Phipps
William Blair
William Blair
―
Buy
―
Reiterated
08/17/26
Argenx: Buy Rating Affirmed on Robust Phase III Vyvgart Myositis Data and Multi-Billion Revenue Potential
RBC Capital Analyst forecast on ARGX
Luca Issi
RBC Capital
RBC Capital
$1,025→$1,100
Buy
19.80%
Upside
Reiterated
08/17/26
Analysts Are Bullish on These Healthcare Stocks: Argenx Se (ARGX), Tenon Medical, Inc. (TNON)
UBS Analyst forecast on ARGX
Xian Deng
UBS
UBS
$850→$960
Hold
4.55%
Upside
Reiterated
08/06/26
UBS Sticks to Its Hold Rating for Argenx Se (ARGX)
Guggenheim Analyst forecast on ARGX
Yatin Suneja
Guggenheim
Guggenheim
$1,185
Buy
29.05%
Upside
Initiated
08/04/26
Argenx resumed with a Buy at GuggenheimArgenx resumed with a Buy at Guggenheim
Stifel Nicolaus Analyst forecast on ARGX
Alex Thompson CFA
Stifel Nicolaus
Stifel Nicolaus
$1,255→$1,282
Buy
39.62%
Upside
Reiterated
07/28/26
Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT) and Argenx Se (NASDAQ: ARGX)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
H.C. Wainwright Analyst forecast on ARGX
Douglas Tsao
H.C. Wainwright
H.C. Wainwright
$1,202
Buy
30.91%
Upside
Reiterated
08/18/26
Argenx price target raised to $1,202 from $940 at H.C. WainwrightArgenx price target raised to $1,202 from $940 at H.C. Wainwright
Wedbush Analyst forecast on ARGX
David Nierengarten
Wedbush
Wedbush
$1,050→$1,150
Buy
25.24%
Upside
Reiterated
08/18/26
Argenx price target raised to $1,150 from $1,050 at WedbushArgenx price target raised to $1,150 from $1,050 at Wedbush
Morgan Stanley Analyst forecast on ARGX
Sean Laaman
Morgan Stanley
Morgan Stanley
$1,200→$1,230
Buy
33.95%
Upside
Reiterated
08/18/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Argenx Se (NASDAQ: ARGX), Fulcrum Therapeutics (NASDAQ: FULC) and OmniAb (NASDAQ: OABI)
Citizens JMP Analyst forecast on ARGX
Jason Butler
Citizens JMP
Citizens JMP
$932→$1,200
Buy
30.69%
Upside
Reiterated
08/18/26
Argenx price target raised to $1,200 from $932 at CitizensArgenx price target raised to $1,200 from $932 at Citizens
Truist Financial Analyst forecast on ARGX
Danielle Brill
Truist Financial
Truist Financial
$1,030→$1,095
Buy
19.25%
Upside
Assigned
08/18/26
Argenx price target raised to $1,095 from $1,030 at TruistArgenx price target raised to $1,095 from $1,030 at Truist
Oppenheimer Analyst forecast on ARGX
Leland Gershell
Oppenheimer
Oppenheimer
$1,037→$1,100
Buy
19.80%
Upside
Reiterated
08/18/26
Argenx price target raised to $1,100 from $1,037 at OppenheimerArgenx price target raised to $1,100 from $1,037 at Oppenheimer
Citi Analyst forecast on ARGX
Samantha Semenkow
Citi
Citi
$1,203→$1,301
Buy
41.69%
Upside
Reiterated
08/18/26
Argenx Se (ARGX) Receives a Buy from Citi
TD Cowen Analyst forecast on ARGX
Yaron Werber
TD Cowen
TD Cowen
$1,146→$1,353
Buy
47.35%
Upside
Reiterated
08/17/26
Analysts Offer Insights on Healthcare Companies: Argenx Se (NASDAQ: ARGX) and Amgen (NASDAQ: AMGN)
Piper Sandler Analyst forecast on ARGX
Allison Bratzel
Piper Sandler
Piper Sandler
$1,075→$1,215
Buy
32.32%
Upside
Reiterated
08/17/26
Argenx price target raised to $1,215 from $1,075 at Piper SandlerArgenx price target raised to $1,215 from $1,075 at Piper Sandler
Bank of America Securities Analyst forecast on ARGX
Tazeen Ahmad
Bank of America Securities
Bank of America Securities
$1,088→$1,136
Buy
23.72%
Upside
Reiterated
08/17/26
Argenx price target raised to $1,136 from $1,088 at BofAArgenx price target raised to $1,136 from $1,088 at BofA
William Blair Analyst forecast on ARGX
Matt Phipps
William Blair
William Blair
―
Buy
―
Reiterated
08/17/26
Argenx: Buy Rating Affirmed on Robust Phase III Vyvgart Myositis Data and Multi-Billion Revenue Potential
RBC Capital Analyst forecast on ARGX
Luca Issi
RBC Capital
RBC Capital
$1,025→$1,100
Buy
19.80%
Upside
Reiterated
08/17/26
Analysts Are Bullish on These Healthcare Stocks: Argenx Se (ARGX), Tenon Medical, Inc. (TNON)
UBS Analyst forecast on ARGX
Xian Deng
UBS
UBS
$850→$960
Hold
4.55%
Upside
Reiterated
08/06/26
UBS Sticks to Its Hold Rating for Argenx Se (ARGX)
Guggenheim Analyst forecast on ARGX
Yatin Suneja
Guggenheim
Guggenheim
$1,185
Buy
29.05%
Upside
Initiated
08/04/26
Argenx resumed with a Buy at GuggenheimArgenx resumed with a Buy at Guggenheim
Stifel Nicolaus Analyst forecast on ARGX
Alex Thompson CFA
Stifel Nicolaus
Stifel Nicolaus
$1,255→$1,282
Buy
39.62%
Upside
Reiterated
07/28/26
Analysts Offer Insights on Healthcare Companies: Summit Therapeutics (NASDAQ: SMMT) and Argenx Se (NASDAQ: ARGX)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AVBPArriVent BioPharma, Inc.
BTSGBrightSpring Health Services, Inc.
AMLXAmylyx Pharmaceuticals Inc
IMMXImmix Biopharma
JBIOJade Biosciences
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Argenx Se

3 Months
Yatin SunejaGuggenheim
Success Rate
17/21 ratings generated profit
81%
Average Return
+7.94%
Copying Yatin Suneja's trades and holding each position for 3 Months would result in 80.95% of your transactions generating a profit, with an average return of +7.94% per trade.
1 Year
Tazeen AhmadBank of America Securities
Success Rate
27/27 ratings generated profit
100%
Average Return
+33.51%
Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +33.51% per trade.
2 Years
Akash TewariJefferies
Success Rate
29/29 ratings generated profit
100%
Average Return
+72.78%
Copying Akash Tewari's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +72.78% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ARGX Analyst Recommendation Trends

Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
5
5
5
4
1
Buy
24
33
51
72
64
Hold
3
3
2
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
32
41
58
78
67
In the current month, ARGX has received 65 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. ARGX average Analyst price target in the past 3 months is 1,143.90.
Each month's total comprises the sum of three months' worth of ratings.

ARGX Financial Forecast

ARGX Earnings Forecast

Next quarter’s earnings estimate for ARGX is $7.65 with a range of $6.38 to $9.47. The previous quarter’s EPS was $7.32. ARGX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ARGX has Performed in-line its overall industry.
Next quarter’s earnings estimate for ARGX is $7.65 with a range of $6.38 to $9.47. The previous quarter’s EPS was $7.32. ARGX beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ARGX has Performed in-line its overall industry.

ARGX Sales Forecast

Next quarter’s sales forecast for ARGX is $1.65B with a range of $1.53B to $1.72B. The previous quarter’s sales results were $2.82B. ARGX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ARGX has Performed in-line its overall industry.
Next quarter’s sales forecast for ARGX is $1.65B with a range of $1.53B to $1.72B. The previous quarter’s sales results were $2.82B. ARGX beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ARGX has Performed in-line its overall industry.

ARGX Stock Forecast FAQ

What is ARGX’s average 12-month price target, according to analysts?
Based on analyst ratings, Argenx’s 12-month average price target is 1,143.90.
    What is ARGX’s upside potential, based on the analysts’ average price target?
    Argenx has 24.58% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ARGX a Buy, Sell or Hold?
          Argenx has a consensus rating of Strong Buy which is based on 20 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Argenx’s price target?
            The average price target for Argenx is 1,143.90. This is based on 22 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $1,353.00 ,the lowest forecast is $932.00. The average price target represents 24.58% Increase from the current price of $918.22.
              What do analysts say about Argenx?
              Argenx’s analyst rating consensus is a Strong Buy. This is based on the ratings of 22 Wall Streets Analysts.
                How can I buy shares of ARGX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.